Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3121272 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL3121266 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL7824895 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL3121253 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL3485762 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL3119100 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL26051 | 1.00 | — | — | |
| SCHEMBL4526965 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4527511 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4538403 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120061001-A | High-strength nylon fiber composite material and preparation method thereof | 江苏奥凯新材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119735763-A | Temperature-resistant oil well cement fluid loss agent and preparation method thereof | 东营丰信石油科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-118421391-B | Preparation method and application of water-based rolling liquid for rolling power battery aluminum foil | 石家庄新泰特种油有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118421391-A | Preparation method and application of water-based rolling liquid for rolling power battery aluminum foil | 石家庄新泰特种油有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117987127-A | Application of oil displacement agent containing nano carboxyl lignin derivative dispersion liquid in oil and gas exploitation | 辽宁石油化工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-115353679-B | High-strength polyethylene wax-montmorillonite modified polyethylene material and preparation method thereof | 扬州科博新材料有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116768952-A | Amphiphilic nano assembly based on hydrophobic molecules and oligonucleotide chains, preparation method and application | 武汉科技大学 | 2023-09-19 | — | — | CN | claimed |
| CN-115353679-A | High-strength polyethylene wax-montmorillonite modified polyethylene material and preparation method thereof | 扬州科博新材料有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-108484687-A | The preparation method of technetium-99 m labeled triphenylphosphine salt derivative and application | 河南中医药大学 | 2018-09-04 | — | — | CN | claimed |
| US-9714220-B2 | Tetradentate organic ligand H3-MN-16Bn containing long alkyl group, precursor thereof, and method for preparing the same | Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. (TW) | 2017-07-25 | — | — | US | claimed |
| US-20170114009-A1 | TETRADENTATE ORGANIC LIGAND H3-MN-16Bn CONTAINING LONG ALKYL GROUP, PRECURSOR THEREOF, AND METHOD FOR PREPARING THE SAME | Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. (TW) | 2017-04-27 | — | — | US | claimed |
| CN-101646643-B | Method for producing cross-coupled compound | KAO CORP | 2013-06-05 | — | — | CN | claimed |
| US-8283482-B2 | Method for producing cross-coupling compound | KAO CORPORATION (JP) | 2012-10-09 | — | — | US | claimed |
| US-20100048929-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | KAO CORPORATION (JP) | 2010-02-25 | — | — | US | claimed |
| CN-101646643-A | Method for producing cross-coupled compound | KAO CORP JP | 2010-02-10 | — | — | CN | claimed |
| EP-2143705-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | Kao Corporation (JP) | 2010-01-13 | — | — | EP | claimed |
| CN-122057035-A | Pharmaceutical composition and application thereof in preparation of tumor treatment drugs | 山东大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-4734989-A2 | SYNTHESIS AND IN VITRO CHARACTERIZATION OF PROTEOLYSIS TARGETING CHIMERAS (PROTACS) FOR DEGRADATION OF DNA METHYLTRANSFERASE 1 (DNMT1) | Dana-Farber Cancer Institute, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-4105608-A | HIGH IMPACT COMPOSITION OF RING-OPENING POLYMERIZATION PRODUCT | SHOWA DENKO K.K. (JP) | 1978-08-08 | — | — | US | disclosed |
| US-4059561-A | AND A HALOGEN COMPOUND | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048929-A1 | METHOD FOR PRODUCING CROSS-COUPLING COMPOUND | FASN, ELOVL3, ELOVL1 | TSHR 1184/4885LMNA 437/4885NFKB1 1086/4885 |
| US-20170114009-A1 | TETRADENTATE ORGANIC LIGAND H3-MN-16Bn CONTAINING LONG ALKYL GROUP, PRECURSOR THEREOF, AND METHOD FOR PREPARING THE SAME | TST, NAA15, NCL | TSHR 286/4885LMNA 2573/4885NFKB1 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.